Science Explorer Back to mapMap
Discussion
Company · Buffalo · United States

Cleveland BioLabs (United States)

Research works
46
▲ 52% vs 2018-21
Citations
2k
44.1 per fractional work
Top-10% rate
5.4%
all institutions 10.0%
Open access
49%
world 40%
International
22%
world 18%

Not ranked overall: Cleveland BioLabs (United States) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Cleveland BioLabs (United States) work in?

In all years, 57% of research at Cleveland BioLabs (United States) is in Life Sciences, 36% in Health Sciences. Its largest fields are Biochemistry, Genetics and Molecular Biology (37%), Medicine (35%), Immunology and Microbiology (12%). It does 3.0× the world's share of Life Sciences.

Life Sciences: 26 fractional works · 57.4% of its workBiochemistry, Genetics and Molecular Biology: 17 fractional works · 36.7% of its workMolecular Biology: 10 fractional works · 22.2% of its workCancer Research: 3 fractional works · 6.8% of its workGenetics: 2 fractional works · 3.8% of its workBiotechnology: 1 fractional works · 2.2% of its workAging: 0 fractional works · 1.0% of its workCell Biology: 0 fractional works · 0.7% of its workImmunology and Microbiology: 5 fractional works · 11.5% of its workImmunology: 4 fractional works · 8.8% of its workMicrobiology: 1 fractional works · 1.4% of its workParasitology: 0 fractional works · 1.0% of its workVirology: 0 fractional works · 0.4% of its workAgricultural and Biological Sciences: 2 fractional works · 4.6% of its workPlant Science: 1 fractional works · 2.4% of its workAnimal Science and Zoology: 0 fractional works · 1.1% of its workAgronomy and Crop Science: 0 fractional works · 0.5% of its workFood Science: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.2% of its workNeuroscience: 2 fractional works · 4.1% of its workCognitive Neuroscience: 1 fractional works · 1.6% of its workEndocrine and Autonomic Systems: 1 fractional works · 1.6% of its workCellular and Molecular Neuroscience: 0 fractional works · 0.9% of its workPharmacology, Toxicology and Pharmaceutics: 0 fractional works · 0.5% of its workToxicology: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.1% of its workHealth Sciences: 17 fractional works · 36.4% of its workMedicine: 16 fractional works · 35.0% of its workOncology: 3 fractional works · 6.0% of its workEpidemiology: 2 fractional works · 4.8% of its workPulmonary and Respiratory Medicine: 2 fractional works · 4.4% of its workRadiology, Nuclear Medicine and Imaging: 2 fractional works · 3.5% of its workHematology: 1 fractional works · 2.3% of its workGenetics: 1 fractional works · 2.3% of its workNeurology: 1 fractional works · 2.3% of its workPhysiology: 1 fractional works · 1.8% of its workPediatrics, Perinatology and Child Health: 1 fractional works · 1.3% of its workHepatology: 0 fractional works · 0.9% of its workInfectious Diseases: 0 fractional works · 0.9% of its workPublic Health, Environmental and Occupational Health: 0 fractional works · 0.8% of its workPsychiatry and Mental health: 0 fractional works · 0.8% of its workSurgery: 0 fractional works · 0.5% of its workDermatology: 0 fractional works · 0.4% of its workPharmacology: 0 fractional works · 0.4% of its workPathology and Forensic Medicine: 0 fractional works · 0.3% of its workCardiology and Cardiovascular Medicine: 0 fractional works · 0.3% of its workNephrology: 0 fractional works · 0.2% of its workEndocrinology, Diabetes and Metabolism: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.5% of its workVeterinary: 0 fractional works · 0.7% of its workSmall Animals: 0 fractional works · 0.7% of its workNursing: 0 fractional works · 0.4% of its workNutrition and Dietetics: 0 fractional works · 0.4% of its workHealth Professions: 0 fractional works · 0.2% of its workEmergency Medical Services: 0 fractional works · 0.2% of its workPhysical Sciences: 2 fractional works · 5.2% of its workEnvironmental Science: 1 fractional works · 2.6% of its workHealth, Toxicology and Mutagenesis: 0 fractional works · 1.1% of its workEcology: 0 fractional works · 1.0% of its workIndustrial and Manufacturing Engineering: 0 fractional works · 0.2% of its workWater Science and Technology: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.0% of its workEngineering: 1 fractional works · 1.8% of its workBiomedical Engineering: 1 fractional works · 1.3% of its workAerospace Engineering: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.2% of its workChemistry: 0 fractional works · 0.4% of its workOrganic Chemistry: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.2% of its workChemical Engineering: 0 fractional works · 0.2% of its workBioengineering: 0 fractional works · 0.2% of its workMaterials Science: 0 fractional works · 0.1% of its workSocial Sciences: 0 fractional works · 1.0% of its workSocial Sciences: 0 fractional works · 0.7% of its workSociology and Political Science: 0 fractional works · 0.4% of its workTransportation: 0 fractional works · 0.4% of its workPsychology: 0 fractional works · 0.2% of its workSocial Psychology: 0 fractional works · 0.2% of its workALL ITS WORKCleveland BioLabs(United States)46fractional works, all years
Life Sciences57%Physical Sciences5%Health Sciences36%Social Sciences1%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 16 fields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology1736.7%
    2. Immunology and Microbiology511.5%
    3. Agricultural and Biological Sciences24.6%
    4. Neuroscience24.1%
    5. Pharmacology, Toxicology and Pharmaceutics00.5%
    1. Medicine1635.0%
    2. Veterinary00.7%
    3. Nursing00.4%
    4. Health Professions00.2%
    1. Environmental Science12.6%
    2. Engineering11.8%
    3. Chemistry00.4%
    4. Chemical Engineering00.2%
    5. Materials Science00.1%
    1. Social Sciences00.7%
    2. Psychology00.2%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Who are the top researchers at Cleveland BioLabs (United States)?

Ranked on the quality score, Patricia Stanhope-Baker and Alexander V. Gasparian lead among researchers whose main affiliation is Cleveland BioLabs (United States).

  1. 1 Patricia Stanhope-Baker United States · #1,740,988 worldwide 1.4k citations · 15 works
  2. 2 Alexander V. Gasparian United States · #2,062,742 worldwide 1.3k citations · 17 works
All ranked researchers at Cleveland BioLabs (United States)

What are the most cited papers from Cleveland BioLabs (United States)?

The most cited paper from Cleveland BioLabs (United States) is "An Agonist of Toll-Like Receptor 5 Has Radioprotective Activity in Mouse and Primate Models" (Lyudmila G. Burdelya, Vadim I. Krivokrysenko, Thomas C. Tallant et al., 2008), with 707 citations. Next come "Structural Basis of TLR5-Flagellin Recognition and Signaling" (586) and "Small-molecule inhibitor of p53 binding to mitochondria protects mice from gamma radiation" (329).

Most cited papers
#PaperReleasedCitations
1 An Agonist of Toll-Like Receptor 5 Has Radioprotective Activity in Mouse and Primate Models Lyudmila G. Burdelya, Vadim I. Krivokrysenko, Thomas C. Tallant et al. · Science Open access 10 Apr 2008 707
2 Structural Basis of TLR5-Flagellin Recognition and Signaling Sung‐il Yoon, Oleg V. Kurnasov, Venkatesh Natarajan et al. · Science Open access 16 Feb 2012 586
3 Small-molecule inhibitor of p53 binding to mitochondria protects mice from gamma radiation Evguenia Strom, Swati S. Sathe, Pavel G. Komarov et al. · Nature Chemical Biology 23 Jul 2006 329
4 Core circadian protein CLOCK is a positive regulator of NF-κB–mediated transcription Mary L. Spengler, Karen K. Kuropatwinski, Maria Comas et al. · Proceedings of the National Academy of Sciences Open access 15 Aug 2012 325
5 Small molecules that reactivate p53 in renal cell carcinoma reveal a NF-κB-dependent mechanism of p53 suppression in tumors Katerina V. Gurova, Jason E. Hill, Canhui Guo et al. · Proceedings of the National Academy of Sciences Open access 15 Nov 2005 266
All 60 most cited papers, with filters and sorting

Which keywords describe research at Cleveland BioLabs (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Apoptosis, Cancer Therapy, Oxidative Stress, Inflammation, Immunotherapy, Biopharmaceutical Production, Pattern Recognition Receptors and Toll-like Receptors.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Inflammation4▲ 4.2×14 topics
  2. Apoptosis4▲ 24×8 topics
  3. Oxidative Stress4▲ 5.2×14 topics
  4. Cancer Therapy4▲ 13×10 topics
  5. Epidemiology4▲ 1.93×15 topics
  6. Immunotherapy3▲ 10×9 topics
  7. Cancer3▲ 4.6×13 topics
  8. Biopharmaceutical Production2▲ 65×2 topics
  9. Pattern Recognition Receptors2▲ 34×1 topic
  10. Toll-like Receptors2▲ 30×1 topic
  11. Gene Expression2▲ 7.8×4 topics
  12. Genomic Instability2▲ 38×3 topics
  13. DNA Damage2▲ 34×3 topics
  14. Radiotherapy2▲ 12×3 topics
  15. Regulation2▲ 7.2×3 topics
  16. Immune Response2▲ 6.7×8 topics
  17. Chemotherapy2▲ 5.5×6 topics
  18. Gene Therapy2▲ 15×3 topics
  19. Genetic Variants2▲ 18×3 topics
  20. Immunity2▲ 11×4 topics
  21. Genetic Mutations2▲ 6.7×5 topics
  22. Biomonitoring2▲ 27×2 topics
  23. Bystander Effects2▲ 152×1 topic
  24. Radiation2▲ 152×1 topic
  25. Therapy2▲ 15×2 topics
  26. Genomic Integration1▲ 29×2 topics
  27. Monoclonal Antibody1▲ 44×2 topics
  28. Cell Cycle1▲ 48×2 topics
  29. Comet Assay1▲ 66×1 topic
  30. Embryonic Stem Cells1▲ 38×2 topics
  31. Genotoxicity Testing1▲ 66×1 topic
  32. Mammalian Cells1▲ 73×1 topic
  33. Recombinant Protein1▲ 73×1 topic
  34. Tumor Suppression1▲ 24×2 topics
  35. Cancer Treatment1▲ 10×4 topics
  36. Cell Death1▲ 13×3 topics
  37. Genetic Regulation1▲ 14×2 topics
  38. Transcriptional Regulation1▲ 11×4 topics
  39. Vaccine Development1▲ 8.7×3 topics
  40. Anemia1▲ 22×4 topics

Which research topics does Cleveland BioLabs (United States) publish most on?

By volume in 2022-now: Blood groups and transfusion, Erythrocyte Function and Pathophysiology, Blood properties and coagulation and Hemoglobinopathies and Related Disorders.

  1. 1 Blood groups and transfusion Hematology 0 works
  2. 2 Erythrocyte Function and Pathophysiology Physiology 0 works
  3. 3 Blood properties and coagulation Pulmonary and Respiratory Medicine 0 works
  4. 4 Hemoglobinopathies and Related Disorders Genetics 0 works
  5. 5 Neurogenetic and Muscular Disorders Research Genetics 0 works
  6. 6 Hydrogen's biological and therapeutic effects Surgery 0 works
  7. 7 High Altitude and Hypoxia Genetics 0 works
  8. 8 vaccines and immunoinformatics approaches Molecular Biology 0 works
  9. 9 Immunotherapy and Immune Responses Immunology 0 works
  10. 10 Erythropoietin and Anemia Treatment Hematology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available49.1%not open50.9%

World: 40% of research is openly available.

with international co-authors21.7%domestic only78.3%

World: 18% is written across borders.

How has Cleveland BioLabs (United States)'s research output changed?

Output in 2022-2025 was 52% higher than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Cleveland BioLabs (United States) as a percentage of every work published that year, 0.0000045% in 2024.

still counting0.00050%0.0010%0.0015%Cleveland BioLabs (United States)0.0000029% in 202519801990200020102020

Fractional works of Cleveland BioLabs (United States) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Buffalo

All research institutions in Buffalo

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Cleveland BioLabs (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.